Pediatric Bone Marrow Transplant for Acute Lymphoblastic Leukemia (ALL) at Sheba Hospital- JCI accreditated and Top-10 Hospitals 2025 by Newsweek
O que está incluído neste pacote
Procedimentos médicos
- Análise bioquímica do sangue
- Consulta com hematologista
- Análise alargada de sangue
- Biópsia da medula óssea
- Consulta com um onco-hematologista
- Diagnóstico abrangente de leucemia
- Estudo citogenético da medula óssea
- Punção de medula óssea com análise citogenética
- Transplante de medula óssea
- Transplante autólogo de medula óssea
- Transplante alogénico de medula óssea de dador não relacionado
- Transplante alogénico de medula óssea de dador relacionado
- 3 refeições por dia pelo nutricionista
- Serviços de enfermagem 24 horas
- Eletrocardiograma (ECG)
- Exames de sangue
- Radiografia do tórax
- Teste anti-HIV
- Teste anti-HBC
- Teste Anti-HCVAb
- Ecocardiografia
- Hemograma completo (HC)
- Exame de sangue para bioquímica
- PET/TC
- Consulta com um imunologista
- Consulta com cardiologista
- Consulta com um hematologista pediátrico
- Consulta com um pediatra
- Consulta com um onco-hematologista
- Ressonância Magnética do Crânio
- Biópsia
- Hemograma completo com marcadores tumorais e proteinograma
Duração
- 30 dias no hospital
Acomodação
Hospitalização
Transporte
Transfer aeroporto-clínica-aeroporto
Informações adicionais
Pediatric Bone Marrow Transplant for Acute Lymphoblastic Leukemia (ALL)
Sheba Medical Center – Advanced, Personalized Care for Children
At Sheba Medical Center, we understand how overwhelming a diagnosis of Acute Lymphoblastic Leukemia (ALL) can be for both children and their families. Our mission is to provide not only the most advanced medical care available, but also reassurance, clarity, and compassionate support throughout every stage of treatment.
As a global leader in pediatric hemato-oncology, Sheba offers cutting-edge bone marrow transplantation (BMT) for children with ALL particularly in cases where the disease is high-risk, relapsed, or resistant to standard therapies.
When is a Bone Marrow Transplant Needed in ALL?
While many children with ALL respond very well to chemotherapy, some require a more intensive approach to achieve a lasting cure.
A bone marrow transplant may be recommended when:
The leukemia has relapsed
The disease is resistant to treatment
There are high-risk genetic features
A deeper, more durable remission is needed
In these situations, BMT replaces the diseased bone marrow with healthy stem cells helping rebuild a new immune system capable of eliminating leukemia cells.
A Personalized Treatment Strategy
Every child’s condition is unique. At Sheba, treatment decisions are made by a dedicated team of pediatric leukemia and transplant specialists who carefully tailor each plan.
Whenever possible, a matched sibling donor is used.
If no sibling match is available, we actively secure the most suitable donor using advanced matching technologies and global registries, including:
Matched unrelated donors from international donor programs
Haploidentical (half-matched) family donors, such as parents
Cord blood transplantation
Our state-of-the-art HLA and molecular laboratories ensure highly accurate matching, improving safety and transplant success.
Advanced Therapies for Better Outcomes
Sheba is at the forefront of innovation in pediatric ALL treatment, combining transplantation with the latest breakthroughs:
CAR-T cell therapy, often used before transplant in relapsed or refractory ALL to achieve remission
T-cell depletion and CD34+ selection reducing complications such as graft-versus-host disease
Access to international clinical trials and novel therapies
This integrated approach allows us to treat even the most complex cases successfully.
Leading Results in Pediatric ALL
Sheba’s outcomes for pediatric ALL are among the best internationally:
~70–85% success rates in children undergoing transplant in remission
Improved outcomes in relapsed cases through CAR-T integration
Strong long-term survival and quality of life
Our continuous research and clinical expertise ensure that every child benefits from the most advanced care available today.
Care That Supports the Whole Family
At Sheba, we treat more than the disease - we care for the child and their family as a whole. Children are treated in specialized, highly protected environments with advanced infection control, while families receive ongoing support, guidance, and clear communication.
Our team stays closely involved throughout the entire journey, ensuring each child is supported medically and emotionally on the path to recovery.
Why Families Choose Sheba for ALL Treatment
Global leader in pediatric leukemia and bone marrow transplantation
Expertise in high-risk and relapsed ALL
Ability to secure optimal donors even without a family match
Integration of CAR-T therapy and advanced cellular treatments
Multidisciplinary, patient-centered approach
Dedicated services for international families
A Message of Hope
For children facing Acute Lymphoblastic Leukemia, a bone marrow transplant can offer a real chance for cure. At Sheba Medical Center, we combine advanced science with compassionate care helping children overcome leukemia and move forward toward a healthy, hopeful future.
Assistência Bookimed 24/7
- Coordenador médico pessoal
- Arranjos de viagem médica — reserva de passagens aéreas e quartos de hotel com preços especiais de parceiros
- Defesa do paciente durante a viagem médica
Preço do programa
O que NÃO está incluído neste pacote
Médico
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
Como estamos indo?
Sobre a clínica
O Hospital Chaim Sheba (Tel Hashomer) — é uma das maiores clínicas públicas de Israel. Ela é composta por 150 centros e departamentos. A clínica se especializa em oncologia, onco-hematologia, neurocirurgia, pediatria e reabilitação.
Mais de 1.000 médicos trabalham aqui. Sheba recebe anualmente 1 milhão de pacientes. A clínica colabora com o centro oncológico MD Anderson (EUA) e recebeu a acreditação JCI (Joint Commission International) — Comissão Internacional de Qualidade em Serviços de Saúde.
Pagamento e Recompensas
Não pague por nossos serviços
Efetue o pagamento diretamente na clínica ou na conta bancária oficial dela.
Algumas clínicas podem exigir um depósito como parte de sua política.
Divida seus pagamentos com opções de parcelamento.
Ganhe recompensas por indicar amigos ao Bookimed.